Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis b vaccine trials, 1978-1988

American Journal of Epidemiology

Volumn 130, Issue 6, 1989, Pages 1167-1175

  Hessol, Nancy A ^a   Lifson, Alan R ^a   O'malley, Paul M ^a   Doll, Lynda S ^b   Jaffe, Harold W ^b   Rutherford, George W ^a  

^a AIDS Office San Francisco   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Acquired immunodeficiency syndrome; HIV; Homosexuality

Indexed keywords

HEPATITIS B VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BISEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE FACTORS; BISEXUALITY; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VACCINES; HIV SEROPOSITIVITY; HOMOSEXUALITY; HUMAN; INCIDENCE; MALE; PREVALENCE; SAN FRANCISCO; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL HEPATITIS VACCINES;

EID: 0024786972     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a115445     Document Type: Article

References (31)

1. HIV/AIDS surveillance report. Atlanta, GA: Centersfor Disease Control, May 1989:1-16.
2. Centers for Disease Control. Human immunodeficiencyvirus infection in the United States: areview of current knowledge. MMWR 1987;36(suppl):22-7.
3. Szmuness W. Large-scale efficacy trials of hepatitisB vaccines in the USA: baseline data andprotocols. J Med Virol 1979;4:327-40.
4. Schreeder MT, Thompson SE, Hadler SC, et al.Hepatitis B in homosexual men: prevalence ofinfection and factors related to transmission. JInfect Dis 1982;146:7-15.
5. Szmuness W, Stevens CE, Harley EJ, et al. HepatitisB vaccine: demonstration of efficacy in acontrolled clinical trial in a high-risk populationin the United States. N Engl J Med 1980;303:833-41.
6. Francis DP, Hadler SC, Thompson SE, et al. Theprevention of hepatitis B with vaccine: report ofthe Centers for Disease Control multi-center efficacytrial among homosexual men. Ann InternMed 1982;97:362-6.
7. Szmuness W, Stevens CE, Zang EA, et al. Acontrolled clinical trial of the efficacy of the hepatitisB vaccine (Heptavax B): a final reportHepatology 1981;l:377-85.
8. Hadler SC, Francis DP, Maynard JE, et al. Longtermimmunogenlcity and efficacy of hepatitis Bvaccine in homosexual men. N Engl J Med 1986:315:209-14.
9. Szmuness W, Much MI, Prince AM, et al. On therole of sexual behavior in the spread of hepatitisB infection. Ann Intern Med 1975,83:489-95.
10. Centers for Disease Control. Acquired immunedeficiency syndrome (AIDS): precautions for clinicaland laboratory staffs. MMWR 1982;31:677-80.
11. Jaffe HW, Darrow WW, Echenberg DF, et al. Theacquired immunodeficiency syndrome in a cohortof homosexual males: a 6-year follow-up study.Ann Intern Med 1985;103:210-14.
12. Byers RH Jr, Morgan WM, Darrow WW, et al.Estimating AIDS infection rates in the San Franciscocohort. AIDS 1988;2:207-10.
13. Dixon WJ, ed BMDP statistical software. LosAngeles, CA: University of California Press, 1985.
14. Plummer F, Cameron W, Simonsen N, et al. Cofactorsin male-female transmission of HIV. Presentedat the IV International Conference onAIDS, Stockholm, Sweden, June 1988.
15. Cannon RO, Hook EW, Nahmias AJ, et al. Associationof herpes simplex virus type 2 with HIVinfection in heterosexual patients attending sexuallytransmitted disease clinics. Presented at theIV International Conference on AIDS, Stockholm, Sweden, June 1988.
16. Holmberg SD, Gerber AR, Stewart JA, et al. PriorHSV-2 infection as a risk factor for HIV infection.Presented at the IV International Conference onAIDS, Stockholm, Sweden, June 1988.
17. Winkelstein W Jr, Samuel M, Padian NS, et al.The San Francisco Men's Health Study. III. Reductionin human immunodeficiency virus transmissionamong homosexual/bisexual men, 1982- Am J Public Health 1987;76:685-9.
18. Centers for Disease Control. Self-reportedchanges in sexual behaviors among homosexualand bisexual men from the San Francisco CityClinic cohort. MMWR 1987;36:187-9.
19. Hessol NA, O'Malley PM, Lifson AR, et al. Incidenceand prevalence of HIV infection amonghomosexual and bisexual men, 1978-1988. Presentedat the V International Conference onAIDS, Montreal, Canada, June 1989.
20. Moss AR, Bacchetti P, Osmond D, et al. Seropositivefor HIV and the development of AIDS orAIDS related condition: three year follow up ofthe San Francisco General Hospital cohort. BrMed J 1988;296:745-50.
21. Stevens CE, Taylor PE, Zang EA, et al. HumanT-cell lymphotropic virus type III infection in acohort of homosexual men in New York City.JAMA 1986;255:2,167-72.
22. Van Griensven GJP, De Vroome EMM, Goudsmit J, et al. Changes in sexual behaviour and the fallin incidence of HIV infection among homosexualmen. Br Med J 1989;298:218-21.
23. Goedert JJ, Biggar RJ, Weiss SH, et al. Threeyearincidence of AIDS in five cohorts of HTLVIll-infected risk group members. Science 1986;231:992-5.
24. Lifson AR, Hessol NA, Rutherford GW, et al. Thenatural history of HIV infection in a cohort ofhomosexual and bisexual men: clinical manifestations,1978-1989. Presented at the V InternationalConference on AIDS, Montreal, Canada, June 1989.
25. Lifson AR, Rutherford GW, Jaffe HW. The naturalhistory of human immunodeficiency virusinfection. J Infect Dis 1988;158:1360-7.
26. Mufioz A, Wang MC, Bass S, et al. Acquiredimmunodeficiency syndrome (AIDS)-free timeafter human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol 1989; 130:530-9.
27. Hessol NA, Barnhart JL, O'Malley PM, et al. Thenatural history of HIV infection in a cohort ofhomosexual and bisexual men: cofactors for diseaseprogression, 1978-1989. Presented at the VInternational Conference on AIDS, Montreal, Canada, June 1989.
28. Centers for Disease Control. Hepatitis B vaccine:evidence confirming lack of AIDS transmission.MMWR 1984;33:685-6.
29. Stevens CE, Taylor PE, Rubenstein P, et al.Safety of the hepatitis B vaccine. N Engl J Med 1985;312:375-6.
30. Buchbinder SP, Hessol NA, Lifson AR, et al. Theinteraction of HIV and hepatitis B vaccination ina cohort of homosexual and bisexual men. Presentedat the V International Conference onAIDS, Montreal, Canada, June 1989.
31. Hessol NA, O'Malley PM, Lifson AR, et al. Projectionsof the cumulative proportion of HIVinfectedmen who will develop AIDS. Presentedat the 28th Interecience Conference on AntimicrobialAgents and Chemotherapy, Los Angeles, California, October 1988.